chartexchange
EDTUTC-4 New York
Sign up
FeedbackDocs

INMB
INmune Bio Inc. Common stock
stockNASDAQ

At CloseOct 2, 2026 3:59:56 PM EDT
1.93USD+0.259%(0.00)290,238
Pre-marketOct 2, 2026 9:28:30 AM EDT
1.98USD+2.591%(+0.05)
Loading…
Loading…
Market Cap
53.56M
Sector
Healthcare
Industry
Biotechnology
HQ
Boca Raton, FL, USA
Previous Close
$1.93
Beta
2.46
52-Week High
$2.60 2026-09-08
52-Week Low
$1.09 2026-03-31
SMA 50
$2.12
SMA 200
$1.64
Avg. Vol 10D
284,488
Avg. Vol 30D
344,243
Avg. Vol 90D
607,634
Relative Vol
0.84
Shares Out
27.75M
Float
22.13M
Free Float %
79.74%
Short Interest
2,251,105
Short Interest %
10.17%
Days to Cover
7.78
On/Off Exchange
47%/53%
Short Vol %
64.76%
Short Vol % (off-exch)
39.26%
Borrow Fee
1.1700%
Borrow Avail.
650,000
FTDs
1,913
FTDs 30d avg
3,143
FTDs 30d high
5,347
Next Earnings
Oct 29, 2026 (24d)
INMB Profile

inmune bio inc. is a clinical stage immuno-oncology company focused on harnessing the patient's immune system to treat cancer. inkmune, the company's lead product, primes patient's nk cells (natural killer cells) to kill cancer. inmune is targeting residual disease, the cancer cells that survive initial treatments that return to cause the cancer relapse. by controlling residual disease, patients may live longer. using a novel mechanism of action and a precision medicine approach, inkmune therapy should enhance nk cells' ability to eliminate residual disease.

INMB Performance
PeriodPriceDateChangeBeta
1W2.002026-09-28-3.50%1.294
1M2.442026-09-04-20.90%1.794
3M1.672026-07-06+15.92%2.535
6M1.232026-04-06+56.91%2.860
1Y2.082025-10-03-7.21%2.460
2Y5.462024-10-04-64.65%—
5Y18.542021-10-04-89.59%1.586
INMB Stock Summary

INmune Bio Inc. Common stock (NASDAQ:INMB) stock price today is $1.93, and today's volume is 290,238. INMB is up 0.000% today. The 30 day average volume is 344,243. INMB market cap is $53.56M with 27.75M shares outstanding.